+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Bimatoprost"

Antiglaucoma Drugs Global Market Report 2024 - Product Thumbnail Image

Antiglaucoma Drugs Global Market Report 2024

  • Report
  • November 2023
  • 175 Pages
  • Global
From
Ocular Hypertension - Pipeline Insight, 2024 - Product Thumbnail Image

Ocular Hypertension - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 250 Pages
  • Global
From
From
Glaucoma Treatment Market - Forecasts from 2023 to 2028 - Product Thumbnail Image

Glaucoma Treatment Market - Forecasts from 2023 to 2028

  • Report
  • December 2023
  • 140 Pages
  • Global
From
From
Glaucoma - Competitive Landscape, 2023 - Product Thumbnail Image

Glaucoma - Competitive Landscape, 2023

  • Report
  • April 2023
  • 180 Pages
  • Global
From
The Global Ophthalmic Drugs Market - Product Thumbnail Image

The Global Ophthalmic Drugs Market

  • Report
  • October 2018
  • 104 Pages
  • Global
From
Glaucoma: Competitive Landscape to 2026 - Product Thumbnail Image

Glaucoma: Competitive Landscape to 2026

  • Report
  • December 2018
  • 48 Pages
  • Global
From
Global and Chinese Bimatoprost Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Bimatoprost Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 149 Pages
  • China, Global
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

Bimatoprost is a medication used to treat glaucoma and other optical disorders. It is a prostaglandin analog, meaning it works by increasing the outflow of fluid from the eye, reducing intraocular pressure. Bimatoprost is available as a topical ophthalmic solution, and is the only prostaglandin analog approved for the treatment of glaucoma and ocular hypertension. It is also used to treat hypotrichosis, a condition characterized by inadequate or thinning eyelashes. Bimatoprost is a widely used medication in the optical disorders drugs market. It is the most commonly prescribed prostaglandin analog for glaucoma and ocular hypertension, and is also used off-label for other conditions. Bimatoprost is generally well-tolerated, with few side effects. Some companies in the Bimatoprost market include Allergan, Sun Pharmaceuticals, and Pfizer. Show Less Read more